Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-05 Sale | 2021-01-05 8:58 pm | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 1,377 | $55.86 | $76,919 | 31,031 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-03 Option Award | 2021-03-05 5:53 pm | N/A 2031-03-02 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 91,875 | $0 | 91,875 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 8:58 pm | 2020-12-31 N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 4,792 | $0 | 31,031 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 8:58 pm | 2020-12-31 2028-03-20 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 14,375 | $0 | 31,031 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 9:03 pm | N/A 2027-01-02 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 1,500 | $0 | 161,173 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 9:03 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 1,500 | $13.48 | 161,173 (Direct) | View |
| 2020-01-03 Option Award | 2020-03-04 5:27 pm | 2020-01-03 2027-01-02 | Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer | 150,000 | $0 | 160,316 (Direct) | View |